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EDITORIAL 
AGE OF BIOLOGICAL MARKERS 
Way back in 1898 Freud, the propounder of psychoanalysis and enunciator of 
psychological concepts of mental illnesses wrote to his friend Fliess—"I have no desire at 
all to leave the psychology hanging in the air with no organic basis but beyond the 
feeling of conviction (that there must be such a basis), I have nothing either theoretical 
or therapeutic to work on and so I must behave as if confronted by just psychological 
factors only". Later for a long time psychiatrists were obsessed with only psychologi-
cal theories of psychiatric illnesses. As the physical science leapt into the 'jet-age', 
man landed on moon and saw his dreams of establishing space laboratories becoming 
true, side by side the psychiatric medicine has also taken strides and biochemical hypo-
theses for psychotic illnesses have been proposed. Today all over the world scientists 
are trying to identify specific 'biological markers' for these illnesses. 
A biological marker is one that reveals stable characteristics of individual subjects 
with greater inter-individual than intra-mdividual variability; is demonstrable in the 
well state and therefore in the well relatives; is heritable, shows that relatives who are 
like the probands on the observed variable are more likely to have that particular psy-
chiatric illness ; exhibits no deviation in observed values in the ill probands and the 
ill relatives from the values predicted by the genetic model tested. 
Indian researchers have done pioneering work during the past decade or so in 
various fields. Specific dermatoglyphic patterns such as abortive lines, pearl lines, 
Simian creases, single radial based crease, etc.. have been seen to be specifically 
associated with schizophrenia and a different set of pattern to be associated with manic-
depressive illness, and also differences were observed between patients with and with-
out positive family history. Constitutional marker-androgynae and 17-ketosteroid excre-
tion were shown to be lower in psychotics as well as neurotics as compared to controls. 
Specific chromosomal abnormality (an extra X chromosome) was shown to be associated 
with schizophrenia. 
On the biochemical field elevated serum creatinine phosphokinase and quanti-
tatively altered blood levels of proteins in schizophrenia, raised GSF proteins and 
immunoglobulins and serum acetylcholinesterase in depression have been observed. 
Reduced platelet MAO activity in chronic schizophrenics and bipolar affective disorder 
were reported. Differential changes in urinary 5-HIAA in drug responder and nonres-
ponder depressives, and alteration in urinary 17-ketosteroides, 17-hydroxyketosteroids 
and vanylyl mandelic acid in schizophrenics are other biochemical variables studied. 
Studies in endocrinology have revealed various thyroid and adrenal cortex function 
abnormalities in depressives. Dexamethasone suppression test has proved to be the 
most promisi7ig area of research. Normalisation of plasma magnesium after lithium 
therapy and high erythrocyte to plasma lithium ratio as a marker of lithium responders 
have been other observations. Improvement with amphetamine as a predictor of 
response to imipramine and amitryptiline in depressives has been predicted as a potent 
pharmacokinetic marker. Observed higher frequency of blood group 'O' and lowered 
frequency of blood group
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and unipolar depressives has been mcniiomd as an evidence in support o( bipolar uni-
polar dichotomy. 
Thus studies on biological markers have encompassed a wide spectrum of branches 
of human biology. Yet various fields such as electrophy.'-iology, eye blink rate, smooth 
persuit eye movement, cortical evoked potential, HLA system, serum prolactin, skin 
conductance and pupillometery are other areas that have been forwarded in the world 
literature as potential biological markers for schizophrenia but are still untouched by 
Indian investigators. Not only in psychosis, 'lactase infusion test' has been debated to be a 
reliable index for diagnosis of panic disorder—a neurotic illness that was considered only 
in the realm of behavioural sciences till less than a decade back. Potentials arc unlimited 
but only a few of them would be ultimately accepted by science as valid and reliable 
indices as aids in diagnosis, prediction of prognosis and genetic counselling of psychiatric 
illnesses. To identify the right ones is a formidable task ahead. Several studies 
conducted in India provide only indirect evidence in favour of the 'biological marker-
hypotheses', most of them being basic and preliminary, with their results indicating 
only associations. Few have been addressed directly to the genetic aetiology. A time 
has therefore come when we should try to adopt newer research strategies for conduc-
ting researches in behavioural genetics, and should try to embark upon yet unexplored 
areas to identify specific biological markers for Indian patients, not forgeting the social 
and psychological maladaptations in the process. 
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